MedPath
NMPA Approval

Dobutamine Hydrochloride Injection

国药准字H20247037

March 1, 2024

国药准字H32021410

Drug Information

盐酸多巴酚丁胺注射液

注射剂

5ml:100mg(按C₁₈H₂₃NO₃计)

化学药品

March 1, 2024

Company Information

Applicant Company

苏州市吴中区东吴南路2-1号

Manufacturing Company

苏州市吴中区东吴南路2-1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸多巴酚丁胺注射液 - NMPA 批准文号 | MedPath